SBCH: Blockbuster June quarter - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

SBCH: Blockbuster June quarter

Jul 25, 2003

GlaxoSmithkline Consumer Healthcare (SBCH) has posted a strong 27% topline growth during the June quarter. It seems that the company's relaunch strategy for both Horlicks and Boost seems to have rubbed off on the performance. It may also be an indication that the inventory correction undertaken by the company last year is now over. There is a minor difference between our revenue growth and the reported growth due to change in numbers of previous quarter figures.

(Rs m)2QFY032QFY04Change1HFY031HFY04Change
Net Sales 1,561 1,97626.6% 3,416 3,793 11.0%
Other Income 39 6360.4% 80 102 27.4%
Expenditure 1,265 1,59526.1% 2,660 3,062 15.1%
Operating Profit (EBDIT)29638128.8%756731-3.3%
Operating Profit Margin (%)19.0%19.3%22.1%19.3%
Interest (8)4- (5) 7 -
Depreciation 34 91169.3% 68 182 169.0%
Profit before Tax31034912.6%773644-16.7%
Tax 88 12340.0% 257 222 -13.7%
Extraordinary items0-3-0-18-
Profit after Tax/(Loss)2222230.5%516405-21.6%
Net profit margin (%)14.2%11.3%15.1%10.7%
No. of Shares 45.445.445.445.4
Diluted Earnings per share*19.619.622.817.8
P/E Ratio13.514.9

One must remember that the June quarter last year was exceptionally bad for the company. Topline during that period had declined by a huge 26%. If we see from this angle, then the company has only managed to recoup lost ground. But one thing is for sure. The result posted by SBCH this quarter are likely to pep up investor interest towards this malted beverage major once again.

2002 was one of the worst years for the company, wherein it reported a 12.5% dip in topline and nearly 33% decline in profits. Even in the March quarter this year, GSK Consumer had reported a marginal dip in the topline. The strong growth witnessed this quarter is a sign that the company has managed to address topline concerns successfully. This could have been led by new product introductions in an effort to reposition its ageing brands.

Expenses as a % of sales
Finished goods1.3%1.0%0.9%0.9%
Staff cost13.2%10.6%11.7%10.8%
Other exps22.0%25.8%21.8%24.0%
Patent and trademark1.6%1.2%1.1%1.3%
Def. Rev. exps.0.8%0.6%0.7%0.7%

At the operating level, expenses grew almost neck to neck with the topline. Consequently, GSK Consumer did not see significant benefits on the operating margins front. Higher raw material and other expense were the key contributors to the expense growth. Depreciation provisioning also increased on account of the new 26,000 tonne malted food plant at Sonepat. All this resulted in the company declaring almost similar net profits as in the corresponding quarter last year. On a consolidated half year basis, SBCH has clocked an encouraging 11% topline growth, but a 22% bottomline dip. The company has declared an interim dividend of Rs 3.3 per share.

At Rs 266, the stock trades at 15x annualised 1HFY04 earnings with market cap to sales at 1.6x. As said earlier, the strong growth in June quarter topline is likely to perk investor interest towards the stock. We are still awaiting the management's take on the topline growth and whether it is a sustainable trend. But overall, we are enthused by prospects of a turnaround story.

Equitymaster requests your view! Post a comment on "SBCH: Blockbuster June quarter". Click here!


More Views on News

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

What Led to the Massive Surge in the Stock of Jubilant FoodWorks? (Views On News)

Aug 18, 2021

Jubilant FoodWorks hits new high, surges 35% in a month on growth prospects.

Zomato Delivers a Hot Listing. Did You Grab a Bite? (Views On News)

Jul 23, 2021

Zomato scripted history on Friday by becoming India's first unicorn to debut on the stock exchanges.

Jubilant FoodWorks Hits Record High on Strong Sales Recovery in June Quarter (Views On News)

Jul 22, 2021

Jubilant FoodWorks is back in the black, aided by higher revenues despite the second wave disrupting operations.

Varun Beverages Q1 Review: Net Profit Rises Two-Fold; Board Announces 1:2 Bonus Issue (Views On News)

May 4, 2021

Varun Beverages' two-fold jump in profit came on the back of strong volume growth and demand recovery.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks (Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for (Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

The Biggest Winners and Losers in India's Transition to Electric Vehicles (Profit Hunter)

Nov 26, 2021

How India's EV transition could be a major headwind for the incumbents.


Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms


Apr 15, 2020 (Close)


  • Track your investment in GSK CONSUMER with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks